The Clinical Utility of a Computerized Cognitive Assessment to Predict Incident Amnestic Mild Cognitive Impairment and Alzheimer’s Disease

dc.contributor.advisorCallahan, Brandy
dc.contributor.authorDocteur, Natalia Gabriela
dc.contributor.committeememberIsmail, Zahinoor
dc.contributor.committeememberIaria, Giuseppe
dc.date2023-11
dc.date.accessioned2023-09-15T16:45:13Z
dc.date.available2023-09-15T16:45:13Z
dc.date.issued2023-08-09
dc.description.abstractDetecting the initial signs of neurodegeneration is integral for early diagnosis and intervention. Computerized cognitive assessments are accessible, efficient, and precise tools for identifying cognitive impairment and risk of neurodegeneration. While computerized instruments can be feasibly administered repeatedly for longitudinal cognitive monitoring, their clinical utility compared to conventional paper-and-pencil tools is yet unknown. The present study examined the utility of a computerized task, the One Card Learning (OCL) test, to detect conversion to dementia and associate with amyloid (Aβ) imaging markers using single and repeated test administration compared to the Montreal Cognitive Assessment (MoCA) and Rey Auditory Verbal Learning Test (RAVLT). The primary and secondary outcomes were conversion from cognitively normal (CN) to amnestic mild cognitive impairment (aMCI) or Alzheimer’s disease (AD) over a four-year study period and positron emission tomography estimates of Aβ, respectively. Data were collected from the Alzheimer’s Disease Neuroimaging Initiative 3 longitudinal cohort study. Participants were older adults aged 56 to 98 years who were CN at baseline. Results showed that the OCL did not better predict conversion to aMCI or AD from cognitive health compared to the MoCA or RAVLT when assessed at baseline or over repeated administrations. Unadjusted baseline OCL performance associated with Aβ status comparably to the MoCA and RAVLT. While repeated MoCA scores provided the strongest estimate of Aβ accumulation, OCL score trajectories uniquely detected diminished practice effects associated with pathological Aβ accumulation. The OCL may offer distinct clinical utility to detect preclinical AD biomarker accumulation. Future research is needed to examine the application of computerized assessments before they are fully integrated into clinical practice.
dc.identifier.citationDocteur, N. G. (2023). The clinical utility of a computerized cognitive assessment to predict incident amnestic mild cognitive impairment and Alzheimer’s disease (Master's thesis, University of Calgary, Calgary, Canada). Retrieved from https://prism.ucalgary.ca.
dc.identifier.urihttps://hdl.handle.net/1880/117025
dc.identifier.urihttps://doi.org/10.11575/PRISM/41868
dc.language.isoen
dc.publisher.facultyArts
dc.publisher.institutionUniversity of Calgary
dc.rightsUniversity of Calgary graduate students retain copyright ownership and moral rights for their thesis. You may use this material in any way that is permitted by the Copyright Act or through licensing that has been assigned to the document. For uses that are not allowable under copyright legislation or licensing, you are required to seek permission.
dc.subjectComputerized cognitive assessment
dc.subjectComputerized neuropsychological assessment device
dc.subjectDementia
dc.subjectMild cognitive impairment
dc.subjectamyloid beta
dc.subject.classificationPsychology--Clinical
dc.subject.classificationPsychology--Cognitive
dc.subject.classificationPsychometrics
dc.subject.classificationMental Health
dc.titleThe Clinical Utility of a Computerized Cognitive Assessment to Predict Incident Amnestic Mild Cognitive Impairment and Alzheimer’s Disease
dc.typemaster thesis
thesis.degree.disciplinePsychology – Clinical
thesis.degree.grantorUniversity of Calgary
thesis.degree.nameMaster of Science (MSc)
ucalgary.thesis.accesssetbystudentI do not require a thesis withhold – my thesis will have open access and can be viewed and downloaded publicly as soon as possible.
Files
Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
ucalgary_2023_docteur_natalia.pdf
Size:
821.21 KB
Format:
Adobe Portable Document Format
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
2.62 KB
Format:
Item-specific license agreed upon to submission
Description: